Overview
- App Name: Drugs.com - Author/Ownership: Owned and operated by Drugsite Trust, a privately held trust in New Zealand administered by two pharmacists. Content is compiled by an editorial team of registered pharmacists, physicians, and medical journalists utilizing licensed databases from independent suppliers such as the American Society of Health-System Pharmacists (ASHP), Cerner Multum, and IBM Watson Micromedex. - Endorsement: The app is not FDA-licensed or formally endorsed by a government agency or academic institution, which is typical for the mHealth landscape unless an app is designated as a medical device (Mescher et al., 2024). However, its professional content relies on reformatted FDA-approved labeling and AHFS DI content from ASHP. - Clinical Decision-Making: The application serves as a quick-reference tool for point-of-care checks on dosing or interactions, but it is not a validated clinical decision-support system. Literature indicates that popularity and app store ratings do not correlate with clinical performance, meaning providers must apply independent judgment rather than relying solely on the application (Mescher et al., 2024). - Safety: While the content is compiled by medical professionals rather than a purely tech-driven team, a potential risk remains if patients self-interpret dosing or interaction data without provider guidance (Mescher et al., 2024). - Credibility: Credibility is supported by the peer-reviewed, evidence-based foundation of its source databases (ASHP/AHFS DI, FDA labeling, Cerner Multum, Micromedex). According to mHealth evaluation frameworks like the APA App Evaluation Model, this professional sourcing is a strong indicator of credibility (Mescher et al., 2024).